Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Prevention and Treatment of Bone Loss after a Spinal Cord Injury: A Systematic Review

Prevention and Treatment of Bone Loss after a Spinal Cord Injury: A Systematic Review

Top Spinal Cord Inj Rehabil., 2007 · DOI: 10.1310/sci1301-123 · Published: January 1, 2007

Spinal Cord InjuryRehabilitationMusculoskeletal Medicine

Simple Explanation

Preserving bone mass after a spinal cord injury (SCI) is important to reduce the risk of fractures from minimal trauma. After a SCI, bone loss occurs rapidly, with increased calcium excretion and bone mineral loss, potentially stabilizing after 1-2 years but remaining below levels of able-bodied individuals. Treatment options include bisphosphonates to inhibit bone resorption and rehabilitation modalities like electrical stimulation and weight-bearing activities to stimulate muscle and encourage weight-bearing.

Study Duration
Not specified
Participants
313 titles and articles reviewed
Evidence Level
Systematic Review

Key Findings

  • 1
    Moderate evidence supports the use of pharmacology, particularly bisphosphonates, for treating bone loss after SCI.
  • 2
    Evidence supporting non-pharmacological interventions for preventing and treating bone loss after SCI is limited.
  • 3
    First-generation bisphosphonates like Clodronate can prevent decreases in bone mineral density in the hip and knee region, especially in men with paraplegia, while Tiludronate (third-generation) increases total bone volume.

Research Summary

This systematic review assessed literature to provide clinical guidance for optimizing bone health after SCI, focusing on preventing acute bone loss and treating established low bone mass in long-standing SCI. The review found moderate evidence for pharmacological treatment of bone loss, particularly with bisphosphonates, but limited evidence for non-pharmacological interventions. Studies employing rehab modalities had very low numbers of participants and few control groups

Practical Implications

Pharmacological Interventions

Bisphosphonates, especially first and third-generation, show promise in preventing and treating bone loss after SCI, but potential side effects should be considered.

Rehabilitation Strategies

While current evidence for non-pharmacological interventions is limited, further research is needed to optimize rehabilitation modalities for bone health after SCI.

Future Research

Large, prospective longitudinal studies are essential to better understand bone loss etiology and intervention responses after SCI, alongside improved measurement techniques.

Study Limitations

  • 1
    Small sample sizes
  • 2
    Variability in outcome measures
  • 3
    Heterogeneous participant groups

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury